Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
A series of c-Met/histone deacetylase (HDAC) bifunctional inhibitors was designed and synthesized by merging pharmacophores of c-Met and HDAC inhibitors. Among them, the most potent compound, 2o, inhibited c-Met kinase and HDACs, with IC50 values of 9.0 and 31.6 nM, respectively, and showed efficien...
Main Authors: | Qingwei Zhang, Guili Xu, Ya Bao, Minru Jiao, Jianqi Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2020-09-01
|
Series: | Pharmaceutical Fronts |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1722543 |
Similar Items
-
Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
by: Qingwei Zhang, et al.
Published: (2020-06-01) -
Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
by: Hang Dong, et al.
Published: (2019-06-01) -
Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone
by: Yang Lin, et al.
Published: (2020-09-01) -
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
by: Ting He, et al.
Published: (2022-08-01) -
Discovery of Indole-Containing Benzamide Derivatives as HDAC1 Inhibitors with In Vitro and In Vivo Antitumor Activities
by: Xiu Gu, et al.
Published: (2022-06-01)